Vancomycin vs. FidaxomicinVancomycin Taper to Prevent Recurrent Clostridioides Difficile

Sponsor:

McGill University Health Centre/Research Institute of the McGill University Health Centre

Code:

NCT07328971

Conditions

Clostridia Difficile Colitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Fidaxomicin

Vancomycin capsule

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by McGill University Health Centre/Research Institute of the McGill University Health Centre on 2026-06-24.